Earnings Outlook For Seres Therapeutics
Portfolio Pulse from Benzinga Insights
Seres Therapeutics (NASDAQ:MCRB) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $0.55. The company's past performance shows a pattern of share price changes following earnings reports. Shares are currently trading at $4.94 and have seen a 3.73% decrease over the last 52-week period.
August 07, 2023 | 6:02 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Seres Therapeutics is expected to report an EPS of $0.55 in its upcoming earnings report. The company's share price has historically been affected by its earnings reports. Currently, shares are trading at $4.94, down 3.73% over the last year.
The upcoming earnings report is a significant event for Seres Therapeutics. Analysts' EPS estimate is a key factor that could influence the stock price. However, the company's historical performance shows that its share price can be negatively affected even when it misses the EPS estimate by a small margin. Given the recent negative trend in the stock's price, investors may be cautious.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100